Dental Care Clinics in Wickenburg, AZ Accepting Medicare
3 Dental Care Clinics found. Showing 1 - 3
 Troy C. Jones D.m.d.,p.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 821 W Wickenburg Way, Wickenburg, AZ 85390 Phone: 928-684-1000 Fax: 928-684-3485 |
The Good Dentist Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 821 W Wickenburg Way, Wickenburg, AZ 85390 Phone: 928-684-1000 |
Ocotillo Dental Aesthetics Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1175 W Wickenburg Way, Suite 1, Wickenburg, AZ 85390 Phone: 623-217-2948 Fax: 602-428-6860 |
News Archive
Rewrite of the recipe for life - new type of DNA
In a dramatic rewrite of the recipe for life, scientists from Florida today described the design of a new type of DNA with 12 chemical letters instead of the usual four.
Capsules: Obama administration finds 3.1 million young adults gained coverage under law; LGBT community still has hurdles in health care equality
Now on Kaiser Health News' blog, Christian Torres reports on the latest numbers regarding young adults' health insurance coverage: "More than 3 million young adults have gained insurance coverage under the health law, according to the latest government estimate. Obama administration officials touted the benefit Tuesday as an example of how the law is making a difference."
Positive results from Antares Pharma VIBEX MTX clinical study on RA
Antares Pharma, Inc. today announced the positive results of a clinical study evaluating VIBEX MTX, a proprietary auto injector product designed to give a rapid subcutaneous injection of methotrexate (MTX) for the treatment of rheumatoid arthritis.
Study finds decrease in inpatient hospitalizations for the elderly with psychiatric diagnosis
Short-stay inpatient hospitalizations for children and adolescents with a psychiatric diagnosis increased significantly over a 12-year period (1996 to 2007) and decreased for the elderly, according to a report in the early online edition in Archives of General Psychiatry by Joseph C. Blader, Ph.D., Assistant Professor, Department of Psychiatry & Behavioral Science at Stony Brook University School of Medicine.
Incyte's ruxolitinib COMFORT-II Phase III trial in MF meets primary endpoint
COMFORT-II, the second pivotal Phase III trial of Incyte Corporation's investigational Janus kinase inhibitor, ruxolitinib, has met its primary endpoint of significantly reducing spleen size in patients with myelofibrosis, when compared to best available therapy.
› Verified 4 days ago